Literature DB >> 7322375

[Effects of cadralazine (ISF 2469) on water-sodium balance and on essential arterial hypertension].

G C Lavezzaro, D Gastaldo, P Noussan, M Bensoni, J Parini, P F Angelino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7322375

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN： 0026-4725            Impact factor:   1.347


× No keyword cloud information.
  2 in total

Review 1.  Cadralazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  D McTavish; R A Young; S P Clissold
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

2.  Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension.

Authors:  M Catalano; J Parini; M Romano; A Libretti
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.